Back

The impact of intravenous ferric carboxymaltose on reverse electrical remodeling following cardiac resynchronization therapy

17 April 2023 (13:00 - 13:55)
Organised by:
Congress Presentation Part of: ePoster session 26 Clinical EHRA Premium Access EHRA 2023

About the speaker

Photo
Professor Evin Bozcali

Basaksehir Cam and Sakura City Hospital, Istanbul (Turkiye)

9 More presentations in this session

Presentation thumbnail
Trends in the use of implantable loop recordertrends and diagnostic rate of the implantable loop recorder in nationwide database
Doctor S. Roh (Seoul, KR)
Abstract Slides
Presentation thumbnail
QRS progression over time in heart failure patients: a robust marker of disease progression irrespective of aetiology
Slides
Presentation thumbnail
Very high power- short duration radiofrequency ablation in patients with congenital heart disease and atrial fibrillation: safety and outcome
Doctor S. Lengauer (Munich, DE)
Abstract Slides
Presentation thumbnail
Pulsed field ablation for atrial tachycardia following prior persistent atrial fibrillation ablation and resistant to radiofrequency energy
Associate Professor M. Fiala (Brno, CZ)
Abstract Slides
Presentation thumbnail
Systematic identification of low voltage-high frequency electrogram zones at sites of left atrial reentrant tachycardia termination
Doctor L. Guido Lopez (Buenos Aires, AR)
Abstract Slides

Access the full session

Session thumbnail
ePoster session 26

The Event

Event poster

EHRA 2023

17 April 2023 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Usefulness of iron deficiency in the prediction of response to cardiac resincronization therapy
29 June 2021
thumbnail
ESC Journals
Impact of angiotensin-receptor neprilysin inhibitor on reverse cardiac remodeling in patients with heart failure with reduced ejection fraction (hfref)
4 February 2022
thumbnail
Congress Presentation
Intravenous iron administration in patients with heart failure alters endothelial homeostasis with early release of endothelial microvesicles and subsequent mobilization of endothelial progenitor cell
25 August 2023
thumbnail
Congress Session
When to consider device therapy in HFrEF
20 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources